Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Feb 15;15:577–588. doi: 10.2147/DDDT.S291865

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 Xu et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

The effects of quercetin combined with cisplatin on the cell proliferation in cervical cancer cells. HeLa (A) and SiHa (B) cells were treated with control (complete culture medium), quercetin (15 μM for HeLa and 30 μM for SiHa), cisplatin (10 μM for HeLa and 12 μM for SiHa) or the co-treatment of quercetin and cisplatin. The ratios of cell proliferation were assessed by BrdU assay. The bars represent the ratios of cell proliferation in each group. Data of HeLa (C) and SiHa (D) are expressed as means ± SD deviation of three independent experiments. *P < 0.05 vs control group, ^#P < 0.05 vs cisplatin group.

Abbreviation: BrdU, bromodeoxyuridine.